Literature DB >> 20096470

Long-term active immunization with a synthetic peptide corresponding to the second extracellular loop of β1-adrenoceptor induces both morphological and functional cardiomyopathic changes in rats.

Lin Zuo1, Haijun Bao, Jue Tian, Xiaoliang Wang, Suli Zhang, Zhongmei He, Li Yan, Rongrui Zhao, Xin L Ma, Huirong Liu.   

Abstract

BACKGROUND: β1-adrenoceptors (β1-ARs) are the predominant receptors in regulating heart functions. β1-ARs contain 7-transmembrane domains (7TM), 3 extracellular loops and 3 intracellular loops. Among these loops, the second extracellular loop of β1-AR (β1-AR-ECII) plays an important role in the pathogenesis of heart failure.
METHODS: (1) Select the sera-negative rats for antibodies against β1-AR-ECII. (2) Detect the level of antibodies against β1-AR-ECII in the process of active immunization with artificial synthetic peptides according to the sequence of human β1-AR-ECII. (3) Observe its long-term role on cardiac structure and function in vivo by immunizing rats. (4) Detect the changes of T lymphocytes subsets in the process of active immunization.
RESULTS: The peptides induced the production of specific autoantibody against β1-AR-ECII. Furthermore, immunization with β1-AR-ECII peptide induced both morphological and functional alterations in the hearts of rats, which potentially results in heart failure. In addition, induction of the autoantibodies against β1-AR-ECII increased the CD4+/CD8+ ratio in the peripheral blood of rats. DISCUSSION: In this study, we determined the effect of anti-β1-AR-ECII autoantibody on morphological and functional cardiomyopathic alterations by immunization of rats with a synthetic peptide corresponding to the β1-AR-ECII for 18 months. These results provide further evidence that autoantibody against β1-AR-ECII is involved in the pathogenesis of heart failure. But the underlying mechanisms need further study.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096470     DOI: 10.1016/j.ijcard.2009.12.023

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  16 in total

1.  Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats.

Authors:  Annekathrin Haberland; Gerd Wallukat; Sabine Berg; Angela-Martina Schulz; Ernst-Joachim Freyse; Roland Vetter; Eckhard Salzsieder; Johannes Müller; Reinhold Kreutz; Ingolf Schimke
Journal:  Mol Cell Biochem       Date:  2014-04-18       Impact factor: 3.396

Review 2.  Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function.

Authors:  L R Herda; S B Felix; F Boege
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Mitochondrial Ultrastructural Alterations and Declined M2 Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M2 Muscarinic Receptor.

Authors:  Suli Zhang; Zhongmei He; Jin Wang; Li Wang; Ye Wu; Jie Wang; Tingting Lv; Huirong Liu
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

4.  Decreased autophagy: a major factor for cardiomyocyte death induced by β1-adrenoceptor autoantibodies.

Authors:  L Wang; H Hao; J Wang; X Wang; S Zhang; Y Du; T Lv; L Zuo; Y Li; H Liu
Journal:  Cell Death Dis       Date:  2015-08-27       Impact factor: 8.469

5.  Circulating miR-185 might be a novel biomarker for clinical outcome in patients with dilated cardiomyopathy.

Authors:  Miao Yu; Wei Liang; Yu Xie; Qi Long; Xiang Cheng; Yu-Hua Liao; Jing Yuan
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

6.  β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.

Authors:  Yunhui Du; Li Yan; Jin Wang; Wenzhang Zhan; Kai Song; Xue Han; Xiao Li; Jimin Cao; Huirong Liu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

7.  Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.

Authors:  Jin Wang; Meixia Li; Xiurui Ma; Kehua Bai; Li Wang; Zi Yan; Tingting Lv; Zhiqing Zhao; Rongrui Zhao; Huirong Liu
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

8.  Decreased autophagy in rat heart induced by anti-β1-adrenergic receptor autoantibodies contributes to the decline in mitochondrial membrane potential.

Authors:  Li Wang; Keyi Lu; Haihu Hao; Xiaoyu Li; Jie Wang; Ke Wang; Jin Wang; Zi Yan; Suli Zhang; Yunhui Du; Huirong Liu
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

9.  Autoantibodies against β1-adrenoceptor induce blood glucose enhancement and insulin insufficient via T lymphocytes.

Authors:  Yulin Gong; Haiyan Xiong; Yunhui Du; Ye Wu; Suli Zhang; Xiao Li; Huirong Liu
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

10.  Proliferation in cardiac fibroblasts induced by β1-adrenoceptor autoantibody and the underlying mechanisms.

Authors:  Tingting Lv; Yunhui Du; Ning Cao; Suli Zhang; Yulin Gong; Yan Bai; Wen Wang; Huirong Liu
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.